Key Takeaways ADMA Biologics (ADMA) markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases. Intellia Therapeutics (NTLA) is a biopharmaceutical company focused on advancing CRISPR gene-editing and related technologies to develop potentially curative therapies for severe diseases. Leveraging deep expertise in science, technology, and clinical development, the company aims to transform patient care by targeting the underlying causes of disea ...